Clinical trial
Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men
NCT00309855 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00309855 |
|---|---|
| Title | Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men |
| Official title | Mechanisms of Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men: Modulation of GHRH, GHRP and Somatostatin Action by Estrogenic Versus Androgenic Steroids |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Aging |
| Intervention type | Drug |
| Interventions | Placebo, Testosterone, Anastrazole, Dutasteride |
| Enrollment | 80 |
| Start date | Dec 1, 2005 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Apr 3, 2006 |
| Last update posted | Jul 31, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: